Reducing Hereditary Cancer Act
Last action on Apr 10, 2025Received in the Senate and Read twice and referred to the...
Take Action
Summary
Reducing Hereditary Cancer Act
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Lifecycle of the Bill
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Apr 10, 2025
